A 32-year-old man from rural Maharashtra presents with hypopigmented macules on his face and trunk with loss of sensation. Slit-skin smear examination is positive. Which investigation is most appropriate to confirm the diagnosis and classify the type of leprosy before initiating MDT?

Explanation

## Classification and Diagnosis of Leprosy **Key Point:** Skin biopsy with histopathology is the gold standard investigation to **confirm the diagnosis** of leprosy and **classify the type** (tuberculoid vs. lepromatous spectrum), which directly guides MDT regimen selection. ### Why Skin Biopsy with Histopathology? The stem asks for the investigation to **confirm diagnosis AND classify type** before initiating MDT. Skin biopsy fulfills both requirements: - **Confirms diagnosis:** Demonstrates characteristic histological features of leprosy (granulomas, nerve involvement, AFB within macrophages) - **Classifies type:** - **Tuberculoid (TT/BT):** Well-formed epithelioid granulomas with lymphocytic infiltration, nerve destruction; AFB absent or scanty - **Lepromatous (LL/BL):** Foamy (Virchow) macrophages packed with AFB, subepidermal clear zone, poor granuloma formation - **Borderline types (BB):** Intermediate histological features Per **Ridley-Jopling classification** (the internationally accepted standard), histopathology is the definitive method for classifying leprosy across the spectrum (TT → BT → BB → BL → LL), which determines MDT regimen (PB: 6 months vs. MB: 12 months). ### Why Not the Other Options? | Investigation | Limitation in This Context | |---|---| | **Slit-skin smear (AFB grading)** | Already reported positive in the vignette; quantifies bacterial load (BI) but cannot classify across the full Ridley-Jopling spectrum or confirm diagnosis histologically | | **Lepromin test (Mitsuda)** | Assesses cell-mediated immunity; useful for prognosis but **not a diagnostic test** — it is positive in healthy individuals too; does not confirm leprosy diagnosis | | **Nerve conduction studies** | Functional assessment of nerve damage; does not confirm diagnosis or classify leprosy type | **High-Yield:** The lepromin test is **not a diagnostic test** for leprosy — it merely reflects the host's immune response to *M. leprae* antigens. It cannot confirm leprosy in a patient who has not been diagnosed. Skin biopsy is the investigation that both confirms and classifies, as per **Park's Textbook of Preventive and Social Medicine** and **Iyer's Dermatology**. **Clinical Pearl:** In the NLEP (National Leprosy Eradication Programme) framework, clinical classification (PB vs. MB) is used for field settings, but when investigation is required to confirm AND classify — especially in a smear-positive case needing histological correlation — **skin biopsy with histopathology** is the most appropriate and definitive investigation (Harrison's Principles of Internal Medicine, 21st ed.; Rook's Textbook of Dermatology).